Floriane Jochum

13PUBLICATIONS
47CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 29, 2026
Maternal and Neonatal Complications Associated with Breast Cancer Systemic Treatments-A VigiBase Disproportionality Analysis Study.

|Jul 07, 2026
Efficacy of secondary cytoreductive surgery for relapsed ovarian low-grade serous carcinoma: a multicenter analysis from French TMRG network.

|Sep 26, 2025
Impact of Antihypertensive Treatment on Outcomes of Adjuvant Bevacizumab for Ovarian Cancer (IATRO), Results from a Nationwide Emulated Clinical Trial.

Floriane Jochum, Élise Dumas, Joe-Elie Salem

|Jun 16, 2025
Comedications Associated with Immune-Related Adverse Events from Immune-Checkpoint Inhibitors.

Léonard Laurent, Baptiste Abbar, Kevin Bihan

|May 29, 2025
BCR::ABL1 Tyrosine Kinase Inhibitors During Pregnancy, a Disproportionality Analysis of Vigibase.

Aurélie Cabannes-Hamy, Rayan Kabirian, Floriane Jochum

|Mar 05, 2025
Explaining the Relationships Between Age, Endocrine Therapy Persistence, and Risk of Recurrence in Hormone Receptor-Positive Early Breast Cancer: A Nationwide Cohort Study.

Elise Dumas, Floriane Jochum, Florence Coussy

Pageof 3

Frequent Collaborators

6 joint publications

Anne-Sophie Hamy

5 joint publications

Paul Gougis

4 joint publications

Enora Laas

4 joint publications

Elise Dumas